PDEF downregulates stathmin expression in prostate cancer

Author：

ISSN： 1019-6439

Source： International Journal of Oncology, Vol.40, Iss.6, 2012-01, pp. : 1889-1899

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prostate-derived Ets transcription factor (PDEF) downregulates survivin expression and inhibits breast cancer cell growth in vitro and xenograft tumor formation in vivo

By Ghadersohi Ali Pan Dalin Fayazi Zahra Hicks David Winston Janet Li Fengzhi

Breast Cancer Research and Treatment, Vol. 102, Iss. 1, 2007-03 ,pp. : 19-30

Springer Publishing Company

Access to resources Recommend Favorite

Intermediate filament expression in prostate cancer

By Nagle R.B.

Cancer and Metastasis Reviews, Vol. 15, Iss. 4, 1996-12 ,pp. : 473-482

Springer Publishing Company

Access to resources Recommend Favorite

Decreased expression of ferroportin in prostate cancer

By Xue Dong Zhou CuiXing Shi YunBo Lu Hao He XiaoZhou

Oncology Letters, Vol. 10, Iss. 2, 2015-08 ,pp. : 913-916

Spandidos Publications

Access to resources Recommend Favorite

MicroRNA-185 downregulates androgen receptor expression in the LNCaP prostate carcinoma cell line

Molecular Medicine Reports, Vol. 11, Iss. 6, 2015-01 ,pp. : 4625-4632

Spandidos Publications

Access to resources Recommend Favorite

Expression of the multidrug resistance gene in human prostate cancer

By Bhangal G. Halford S. Wang J. Roylance R. Shah R. Waxman J.

Urologic Oncology: Seminars and Original Investigations, Vol. 5, Iss. 3, 2000-04 ,pp. : 118-121

Elsevier

Access to resources Recommend Favorite